Novartis Shareholders Approve The Proposed 100% Spin-off Of Sandoz, Shareholders Also Approve A Reduction Of Share Capital In Connection With The Spin-off
Portfolio Pulse from Benzinga Newsdesk
Novartis shareholders have approved the proposed 100% spin-off of Sandoz. In connection with the spin-off, shareholders also approved a reduction of share capital.
September 15, 2023 | 9:48 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Novartis shareholders have approved the 100% spin-off of Sandoz, which could potentially impact the company's stock price.
The approval of the spin-off of Sandoz and the reduction of share capital could lead to changes in the company's stock price. However, the direction of the impact is uncertain and depends on various factors, including market perception of the spin-off and the company's future plans.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100